Market Cap 137.12B
Revenue (ttm) 402.07B
Net Income (ttm) 1.77B
EPS (ttm) N/A
PE Ratio 15.06
Forward PE 14.28
Profit Margin 0.44%
Debt to Equity Ratio 0.81
Volume 6,608,600
Avg Vol 8,587,376
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 77%
Beta 0.61
Analysts Strong Sell
Price Target $111.62

Company Profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
gpaisa
gpaisa Jul. 18 at 9:27 PM
$CVS trend shifts are such a powerful observation. As Jack Straus famously said, all you need "is a chip and chair".
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 18 at 12:16 AM
$CVS Share Price: $107.48 Contract Selected: Aug 14, 2026 $105 Calls Buy Zone: $4.67 – $5.78 Target Zone: $7.47 – $9.13 Potential Upside: 51% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Invest2live
Invest2live Jul. 17 at 10:13 PM
$CVS 74% already; congrats 🌿🌷🔆 Checkout $AKBA and $IBM
0 · Reply
amda
amda Jul. 17 at 6:27 PM
$DCGO a buyout of $DCGO by any of these huge insurance companies would make a lot of sense and could be easily made with merely their pocket change: $UNH $CVS $ELV
0 · Reply
amda
amda Jul. 17 at 5:50 PM
$DCGO $DCGO Nuclear Elvis -how about this edited version? Feel free to make your own edits and repost elsewhere as appropriate $DCGO for newcomers: DOCGO is not your typical penny stock. The company has $300 million in revenues. All government business has been written down to zero, so there is no further overhang. Legacy business lines are all growing and the new acquisition, Steady MD, is growing rapidly as a partner provider for Amazon's healthcare arm. The value of this relationship for $DCGO’s accelerating growth cannot be understated. Virtually NO DEBT and an extension of the stock buyback program has recently been announced. Company projects a return to profitability in the second half of 2026. With a market cap of LESS THAN 25% OF REVENUES, this represents a compelling opportunity imo. $UNH $CVS $ELV Bullish
1 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Jul. 17 at 5:01 PM
$CVS printed a new 52-week high today
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 17 at 4:05 PM
0 · Reply
amda
amda Jul. 17 at 2:03 PM
$DCGO for newcomers: DOCGO is not your typical penny stock. The company has $300 million in revenues. All government business has been written down to zero, so there is no further overhang. Legacy business lines are all growing, and the new acquisition is growing rapidly. Virtually NO DEBT and an extension of the stock buyback program has recently been announced. Company projects a return to profitablilty in the second half of 2026. With a market cap of LESS THAN 25% OF REVENUES, this represents a compelling opportunity imo. $UNH $CVS $ELV
2 · Reply
gabbs
gabbs Jul. 16 at 2:55 PM
$CVS Closed my position at $108. Built the position over several years, reinvested dividends, added heavily in the high-$60S to low-$80S range, and exited with roughly a 48% total return and a 51% annualized return. One of my best completed trades. On to the next opportunity. #CVS Still looks good for a longer, but need to keep reducing positins, simplifying, and increasing my broad market allocation. Good luck longs!
1 · Reply
PenguinVision
PenguinVision Jul. 16 at 1:05 PM
$UNH Q2 EARNINGS Investors are watching key areas including: Revenue growth and medical cost trends UnitedHealthcare membership trends Optum expansion and healthcare service growth Full-year guidance outlook After recent volatility, the market reaction will depend not only on the numbers, but also on management’s forward outlook and confidence in future margins. Key levels and price action will determine whether buyers step back in or if more consolidation is needed. Related healthcare names to watch: $CVS - healthcare services and insurance exposure $CI - managed care sector momentum Charts tell the story before headlines do. View my profile to learn more about the setups and market analysis I’m watching. Every update builds a bigger picture.
0 · Reply
Latest News on CVS
CVS Health price target raised to $118 from $108 at Truist

2026-07-14T11:50:32.000Z - 5 days ago

CVS Health price target raised to $118 from $108 at Truist


CVS Health declares quarterly dividend

Jul 10, 2026, 9:48 AM EDT - 9 days ago

CVS Health declares quarterly dividend


CVS Health price target raised to $103 from $85 at HSBC

2026-07-06T14:25:49.000Z - 13 days ago

CVS Health price target raised to $103 from $85 at HSBC


The Big 3: CVS, SLV, PLTR

Jul 1, 2026, 1:00 PM EDT - 18 days ago

The Big 3: CVS, SLV, PLTR

PLTR SLV


Choice Hotels names CVS Health’s Ali Keshavarz to board

2026-07-01T14:05:17.000Z - 18 days ago

Choice Hotels names CVS Health’s Ali Keshavarz to board

CHH


Florida  AG subpoenas CVS Health over reimbursement rates

2026-06-23T19:18:07.000Z - 26 days ago

Florida AG subpoenas CVS Health over reimbursement rates


CVS Health price target raised to $110 from $100 at BofA

2026-06-23T11:32:25.000Z - 26 days ago

CVS Health price target raised to $110 from $100 at BofA


CVS Health announces comprehensive approach to GLP-1 support

2026-06-22T12:14:51.000Z - 27 days ago

CVS Health announces comprehensive approach to GLP-1 support


CVS is Using Fluency to Close Enterprise AI Deployment Gap

Jun 11, 2026, 10:43 AM EDT - 5 weeks ago

CVS is Using Fluency to Close Enterprise AI Deployment Gap


H1 Receives $40M Investment in Round Led by CVS Health Ventures

May 28, 2026, 11:00 AM EDT - 7 weeks ago

H1 Receives $40M Investment in Round Led by CVS Health Ventures


CVS brings back coverage for Lilly's obesity drug Zepbound

May 28, 2026, 6:47 AM EDT - 7 weeks ago

CVS brings back coverage for Lilly's obesity drug Zepbound

LLY


Glenview Capital Issues Statement on CVS Health

May 21, 2026, 4:15 PM EDT - 2 months ago

Glenview Capital Issues Statement on CVS Health


The Big 3: NKE, CVS, CSCO

May 20, 2026, 1:00 PM EDT - 2 months ago

The Big 3: NKE, CVS, CSCO

CSCO NKE


CVS Health Transcript: AGM 2026

May 14, 2026, 8:00 AM EDT - 2 months ago

CVS Health Transcript: AGM 2026


CVS unit Omnicare wins court approval for sale to GenieRx

May 13, 2026, 4:26 PM EDT - 2 months ago

CVS unit Omnicare wins court approval for sale to GenieRx


Omnicare Receives Court Approval for Sale of Business to GenieRx

May 13, 2026, 4:00 PM EDT - 2 months ago

Omnicare Receives Court Approval for Sale of Business to GenieRx


CVS Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

CVS Health Earnings Call Transcript: Q1 2026


CVS Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

CVS Health Earnings release: Q1 2026


CVS Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

CVS Health Quarterly report: Q1 2026


CVS Health Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

CVS Health Slides: Q1 2026


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 2 months ago

CVS to drop J&J's Stelara from its main formularies

JNJ


How CVS Uses Robots to Keep Your Deodorant in Stock

May 1, 2026, 5:30 AM EDT - 2 months ago

How CVS Uses Robots to Keep Your Deodorant in Stock


The Big 3: COST, CVS & MPC

Apr 30, 2026, 1:30 PM EDT - 2 months ago

The Big 3: COST, CVS & MPC

COST MPC


gpaisa
gpaisa Jul. 18 at 9:27 PM
$CVS trend shifts are such a powerful observation. As Jack Straus famously said, all you need "is a chip and chair".
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 18 at 12:16 AM
$CVS Share Price: $107.48 Contract Selected: Aug 14, 2026 $105 Calls Buy Zone: $4.67 – $5.78 Target Zone: $7.47 – $9.13 Potential Upside: 51% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Invest2live
Invest2live Jul. 17 at 10:13 PM
$CVS 74% already; congrats 🌿🌷🔆 Checkout $AKBA and $IBM
0 · Reply
amda
amda Jul. 17 at 6:27 PM
$DCGO a buyout of $DCGO by any of these huge insurance companies would make a lot of sense and could be easily made with merely their pocket change: $UNH $CVS $ELV
0 · Reply
amda
amda Jul. 17 at 5:50 PM
$DCGO $DCGO Nuclear Elvis -how about this edited version? Feel free to make your own edits and repost elsewhere as appropriate $DCGO for newcomers: DOCGO is not your typical penny stock. The company has $300 million in revenues. All government business has been written down to zero, so there is no further overhang. Legacy business lines are all growing and the new acquisition, Steady MD, is growing rapidly as a partner provider for Amazon's healthcare arm. The value of this relationship for $DCGO’s accelerating growth cannot be understated. Virtually NO DEBT and an extension of the stock buyback program has recently been announced. Company projects a return to profitability in the second half of 2026. With a market cap of LESS THAN 25% OF REVENUES, this represents a compelling opportunity imo. $UNH $CVS $ELV Bullish
1 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Jul. 17 at 5:01 PM
$CVS printed a new 52-week high today
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 17 at 4:05 PM
0 · Reply
amda
amda Jul. 17 at 2:03 PM
$DCGO for newcomers: DOCGO is not your typical penny stock. The company has $300 million in revenues. All government business has been written down to zero, so there is no further overhang. Legacy business lines are all growing, and the new acquisition is growing rapidly. Virtually NO DEBT and an extension of the stock buyback program has recently been announced. Company projects a return to profitablilty in the second half of 2026. With a market cap of LESS THAN 25% OF REVENUES, this represents a compelling opportunity imo. $UNH $CVS $ELV
2 · Reply
gabbs
gabbs Jul. 16 at 2:55 PM
$CVS Closed my position at $108. Built the position over several years, reinvested dividends, added heavily in the high-$60S to low-$80S range, and exited with roughly a 48% total return and a 51% annualized return. One of my best completed trades. On to the next opportunity. #CVS Still looks good for a longer, but need to keep reducing positins, simplifying, and increasing my broad market allocation. Good luck longs!
1 · Reply
PenguinVision
PenguinVision Jul. 16 at 1:05 PM
$UNH Q2 EARNINGS Investors are watching key areas including: Revenue growth and medical cost trends UnitedHealthcare membership trends Optum expansion and healthcare service growth Full-year guidance outlook After recent volatility, the market reaction will depend not only on the numbers, but also on management’s forward outlook and confidence in future margins. Key levels and price action will determine whether buyers step back in or if more consolidation is needed. Related healthcare names to watch: $CVS - healthcare services and insurance exposure $CI - managed care sector momentum Charts tell the story before headlines do. View my profile to learn more about the setups and market analysis I’m watching. Every update builds a bigger picture.
0 · Reply
EarlyT
EarlyT Jul. 16 at 12:22 PM
$CVS pre market volume 131.5k price 109 Will it hold? At least it is going in the right direction.
0 · Reply
Reanimated666
Reanimated666 Jul. 16 at 12:10 PM
$CVS Up in sympathy with earnings blowout from $UNH
0 · Reply
Reanimated666
Reanimated666 Jul. 15 at 4:32 PM
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Jul. 15 at 4:31 PM
$CVS printed a new 52-week high today
0 · Reply
EarlyT
EarlyT Jul. 15 at 12:38 PM
$CVS HUM on its way to $500
0 · Reply
cubie
cubie Jul. 15 at 11:54 AM
$ELV no one asked cubie elevance, whales played otm multileg both ways indeed how they know it be a big mover🤔🫡😅.. $UNH $HUM $CVS peeps should've asked cubie bout elv flow🤭😅
0 · Reply
MandelbrotMarkets
MandelbrotMarkets Jul. 14 at 8:23 PM
$CVS Caremark settled with the FTC, agreeing to curb after-market discounts and count TrumpRx purchases toward deductibles. That removes a regulatory overhang and may soften some PBM pressure, but it also keeps the spotlight on pricing power and margin structure. Net: modestly cleaner headline, still a watch item for CVS sentiment.
0 · Reply
PivotalSaints
PivotalSaints Jul. 14 at 1:42 PM
$CVS $IBM $QQQ $SBUX $SPY Thank you cubie for recognizing the historical moment of this moment and morning in the market. It’s the CPI print before my birthday and bears got an Azz whoopin today.
0 · Reply
cubie
cubie Jul. 14 at 1:40 PM
$IBM $QQQ $SPY this is historic have never seen 167,000% on options. seen $CVS $SBUX 30000-60000% and that was previous record.
3 · Reply
myman1956
myman1956 Jul. 13 at 11:53 PM
$CVS With high PE with high oil that a bigger dip in this company that 2 different recessions on oil prices during last 4 years of Vietnam war.
1 · Reply
reversefunnelsystem
reversefunnelsystem Jul. 13 at 4:36 PM
$CVS strong like bull
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Jul. 13 at 3:01 PM
$CVS printed a new 52-week high today
0 · Reply